Brian “Keith” Day, MD, PhD, will assume the role of interim section chief for the Section of Adult Epilepsy. This comes as Edward R. Hogan, MD, steps down from the role in which he has provided exemplary leadership.
Under Hogan’s guidance, the Section of Epilepsy has seen significant growth both in size and scope. His efforts have notably expanded the Department of Neurology’s support for intensive care units and have led to the considerable growth and enhancement of the Epilepsy Monitoring Unit. The department is deeply grateful for Hogan’s dedication and contributions, which have positioned the program as a leader in epilepsy care. Hogan will continue his invaluable work as director of adult epilepsy clinical trials.
Day’s extensive background and contributions to the epilepsy field make him exceptionally qualified for the role of interim section chief. He graduated from Harvard University and earned his MD/PhD at the University of Kentucky before joining Washington University School of Medicine in St. Louis for his neurology residency and clinical neurophysiology fellowship. Day joined the WashU Neurology faculty in 2012 as a clinical instructor in Adult Epilepsy and has since played significant a role in the development and growth of many programs. His commitment and leadership were instrumental in establishing the Barnes-Jewish Hospital EEG Technologist Training School and in coordinating epilepsy surgery, which has supported the expansion of the Epilepsy Monitoring Unit, BJH neurodiagnostic services and surgery program. Notably, he led the implementation and expansion of Stereo/EEG studies.
In 2018, Day initiated the ACGME-accredited Adult Epilepsy Fellowship Program and served as its first program director until 2024. He has served as medical director for BJH neurodiagnostics since 2021 and co-founded the Greater St. Louis Epilepsy Society, which has enriched the St. Louis community through epilepsy education for five years. As part of this transition, Day will hand over the role of fellowship program director to Adam Greenblatt, MD, who has served as associate program director for the past year.
Please join the department in expressing profound gratitude to Hogan for his remarkable leadership and in congratulating Day on his new role as interim section chief. The department looks forward to the continued growth and success of the Epilepsy Section under Day’s leadership.